Japan Market To Benefit from Novel Ingredients and Regulatory Expertise
PROVO, Utah, July 28 /PRNewswire-FirstCall/ -- Nu Skin Enterprises, Inc.
(NYSE: NUS) today announced that the company has signed a memorandum of
understanding for a joint research and development relationship with Toyo
Bio-Pharma, Inc. (a subsidiary of Toyo Shinyaku, Japan), a natural products
manufacturer with facilities in the United States and Japan. To facilitate
this relationship, the companies established a new joint venture, NU Toyo
Research, Inc., in the United States.
Nu Skin Enterprises is the first direct selling company to have such an
agreement with Toyo Bio-Pharma. The companies' collaborative development
efforts will focus on sharing scientific and regulatory insights, as well as
developing proprietary nutraceutical and cosmeceutical products for Nu Skin
sales through its worldwide distribution network.
"We expect this relationship with Nu Skin Enterprises to nicely complement
our current expertise in natural health supplements," said Yoshi Shiraishi,
president and chief operating officer of Toyo Bio-Pharma. "We highly respect
the industry-leading research and development capabilities of Nu Skin
Enterprises. We believe there is a synergy between the two research teams that
both companies can benefit from."
"Toyo Bio-Pharma is a subsidiary of Toyo Shinyaku, which is one of the
most reputable supplement and skin care manufacturers in Japan, and we look
forward to developing a robust relationship with joint development
opportunities," said Joseph Chang, Ph. D., chief scientific officer and
executive vice president of product development at Nu Skin Enterprises. "We
are eager to leverage their knowledge of navigating regulatory requirements
for skin care and supplements in Japan."
About Toyo Bio-Pharma
Toyo Bio-Pharma(TM) (http://www.toyobiopharma.com) is a subsidiary of Toyo
Shinyaku Co., Ltd., a research-driven manufacturer committed to providing
consumers and clients with high-value ingredients derived from nature. With
the most advanced instrumentation, continuous research and commitment to
quality and integrity, Toyo Shinyaku is pioneering the use of fermentation and
culturing to produce beneficial, effective products for use in the
nutraceutical, functional food and cosmeceuticals industries. Toyo Shinyaku
is Japan's largest developer of FOSHU (Food for Specialized Health Use)
products and ODM (Original Design Manufacturer) of supplement and skin care
products. Toyo Shinyaku follows rigorous standards of ISO 9001:2000 and ISO
22000:2005, and was one of the first Japanese companies to become Food and
Drug Administration (FDA) Good Manufacturing Practices (GMP)-compliant for
food products and dietary supplements.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc. is a global direct selling company operating in
47 markets throughout Asia, the Americas and Europe. The company markets
premium-quality personal care products under the Nu Skin(R) brand,
science-based nutritional supplements under the Pharmanex(R) brand, and
technology-based products and services under the Big Planet(R) brand. Nu Skin
Enterprises is traded on the New York Stock Exchange under the symbol "NUS."
More information is available at http://www.nuskinenterprises.com.
SOURCE Nu Skin Enterprises, Inc.
of Nu Skin Enterprises,
of Toyo Bio-Pharma,